FindTrial
Sign In

To study the association of Male pattern baldness and Obesity

To study the association of Androgenetic Alopecia with Metabolic Syndrome and Insulin Resistance in male patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2012/09/003032
Enrollment
80
Registered
2012-09-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Androgenetic Alopecia ( Male Pattern Baldness )

Interventions

None listed

Sponsors

ESIC PGIMSR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Apparently normal males (18-35 years) â?? age defined as age at entry into the study 2. Patients with AGA >= stage III in the Hamiltonâ??Norwood classification

Exclusion criteria

Exclusion criteria: 1. Patients of alopecia other than AGA and men with â??female pattern hair lossâ?? 2. Patients of Diabetes on insulin treatment or receiving insulin sensitizing drugs 3. Patients taking drugs for lipid control, antihypertensive drugs 4. Patients receiving androgen or anti â?? androgen drugs 5. Patients taking hormonal treatment for any known endocrinological abnormality

Design outcomes

Primary

MeasureTime frame
HOMA-IR more than 2.7 favours Insulin ResistanceTimepoint: Evaluation at the time of enrollment—

Secondary

MeasureTime frame
NoneTimepoint: None—

Countries

India

Contacts

Public ContactDr Tapan Kumar Dhali

Employees State Insurance Corporation - Post Graduate Institute of Medical Sciences & Research

dr.himanshu87@gmail.com9968250431

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026